Q-omics provides the consensus-scored HLA-DRB4 profile across patient tissues and cancer cell-line models.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for HLA-DRB4 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with HLA-DRB4 in patient tissues and cancer cell lines. In cancer cell lines, HLA-DRB4 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in BREAST, while CRISPR and shRNA rows add functional-dependency signals in OVARY and BLOOD_Lymphoma.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼shRNA
RNA	1,702	BREAST (349)	view →
shRNA	1,686	OVARY (225)	view →
▼Protein (mass-spec)
RNA	291	BLOOD_Lymphoma (129)	view →
Function (mass-spec)	248	BLOOD_Lymphoma (97)	view →